Ziphius Vaccines NV
Ziphius Vaccines is named after the rare dolphin Ziphius cavirostris. This dolphin is most known for undertaking the deepest and longest dives recorded. Ziphius` mission is to reduce the global impact of infectious diseases on global health care by creating a new generation of transformative vaccines. Ziphius Vaccines is a biopharmaceutical company, dedicated to develop saRNA vaccines and therapeutics. Ziphius focuses on both vaccines for infectious diseases and gene supplementation therapies for rare genetic disorders. Since our founding in 2019, Ziphius has worked to develop and validate its self-amplifying RNA and LNP platforms. Currently, these platforms are being used to rapidly expand our pipeline and move forward multiple preclinical development programs towards the clinic.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
This company also provides solutions for other industrial applications.
Please, visit the following links for more info:
About Us
Ziphius' mission is to reduce the global impact of infectious diseases on global health care by creating a new generation of transformative vaccines.
Based in Belgium, Ziphius' team is composed of 24 members. This is expected to grow exponentially over the next years. Ziphius' team is managed by a team of highly dedicated experts, with a strong scientific, managerial and pharmaceutical background.
To uncover the possibilities of self-amplifying RNA as prophylactic vaccines against infectious diseases and therapeutics for rare genetic disorders.
We address public health needs by developing a self-amplifying RNA-based platform for rapid and scalable manufacturing of innovative medical tools.